Cindy's Story
Lymphoma
Cindy has been married for 30 years and enjoys life centered around family and Cuban traditions. After her husband’s cancer diagnosis, she supported him through treatment and began thinking more about her own health. Though she felt healthy and had no symptoms, his cancer experience made her want to be proactive.
Her Galleri Test Experience
When she learned about the Galleri test during a doctor’s visit, Cindy was interested in its ability to screen for many cancers at once. Still, she hesitated since she “felt fine,” until her husband convinced her to go ahead and take the test.
Test Results and Early Detection
Within weeks of taking the test Cindy received unexpected news. Her doctor told her there was a cancer signal detected and that she needed to go see a hematologist right away, who then confirmed through a biopsy that Cindy had lymphoma.
For Cindy, the early diagnosis was critical because the type of cancer she had is typically aggressive.
“So a lot of times people won’t discover it until a later stage,” she said. “So it’s very rare to get it in the beginning stages because there’s no side effects. I went to a doctor that specializes in my cancer, and he told me that I was one of the earliest stage patients that he’s treated.”
Cindy is grateful to be able to focus on her family and the future.
“I’m so happy that I’m able to still be with my family, still be strong, still be able to be around for my grandkids.”
The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False-positive and false-negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test should be used in addition to healthcare provider recommended screening tests.
The overall sensitivity in study participants with lymphoma was 56.3% (27.3% for stage I, 58.3% stage II, 71.7% stage III, 60.9% stage IV).
Important Safety Information
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g. imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
Laboratory/test information
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed—and its performance characteristics were determined—by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.